Boutique CRO focused on Bioanalytical and Analytical CMC services from characterization to commercialization
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
102
NCT03449524
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
Phase: Phase 2
Role: Collaborator
Start: Aug 1, 2018
Completion: Aug 5, 2020
NCT04053543
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
Start: Aug 9, 2019
Completion: Aug 12, 2020
Loading map...